In the News

The US Food and Drug Administration (FDA) is alerting the public that preliminary results from a safety clinical trial show an increased risk of serious heart-related problems and cancer with the rheumatoid arthritis (RA) and ulcerative colitis drug tofacitinib (Xeljanz, Xeljanz XR), compared with...
Patients with rheumatoid arthritis (RA) may benefit from treatment with monoclonal antibody otilimab, according to a study published in The Lancet Rheumatology. In a multicentre, dose-ranging study, Christopher D. Buckley, University of Birmingham, Birmingham, United Kingdom, and colleagues...
The American College of Rheumatology has published new guidelines for treating and managing systemic juvenile idiopathic arthritis (JIA), oligoarthritis, and temporomandibular joint (TMJ) arthritis. “Our overarching goal with the update project, including part 1 in 2019 and this current project,...
The American College of Rheumatology (ACR) has updated its guideline for the management of rheumatoid arthritis (RA). The new guideline, presented at the 2020 Virtual ACR Meeting was developed by a broad range of stakeholders in RA treatment, including rheumatologists, methodologists, and patients...
Measuring levels of certain small molecules produced from essential fatty acids in a person’s blood that are involved in regulating inflammation can help predict which patients with rheumatoid arthritis (RA) will respond to treatment with disease-modifying antirheumatic drugs (DMARDs), according to...

Conference Reports

By Erika Powers

VIRTUAL -- June 10, 2021 -- In children with juvenile idiopathic arthritis (JIA), a treat to target strategy aimed at inactive disease appeared to reduce pain, according to a study presented at the Virtual 2021 Annual Meeting of the European League Against Rheumatism (...

By Erika Powers

VIRTUAL -- June 10, 2021 -- Patients with psoriatic arthritis who were treated with upadacitinib 15 mg or 30 mg maintained responses for over 56 weeks, with rates numerically higher than treatment with adalimumab, according to a study presented at the Virtual 2021 Annual...

By Erika Powers

VIRTUAL -- June 9, 2021 -- Wearable transcutaneous electrical nerve stimulation was more effective and better tolerated than weak opioids in the treatment of moderate-to-severe nociceptive knee osteoarthritis (OA) pain, according to a study presented at the Virtual 2021...

By Erika Powers

VIRTUAL -- June 9, 2021 -- Clinicians are recommending caution when treating patients with systemic lupus erythematosus (SLE) with belimumab, and suggest active monitoring of renal parameters especially in patients with poor clinical and serological response to belimumab...

By Shazia Qureshi

VIRTUAL -- June 9, 2021 -- When added to standard therapy, intravenous belimumab was well tolerated and effective for patients with lupus nephritis, according to a 6-month open-label extension trial, presented at the Virtual 2021 Congress of the European Renal...

Recently Published

Alvin F Wells, Christopher J Edwards, Alan J Kivitz, Paul Bird, Benoit Guerette, Nikolay Delev, Maria Paris, Lichen Teng, Jacob A Aelion
Joint Bone Spine
P Brito-Zerón, R Pérez-Alvarez, C Feijoo-Massó, B Gracia-Tello, A González-García, R Gómez de-la-Torre, A Alguacil, M López-Dupla, A Robles, J S Garcia-Morillo, M Bonet, G Cruz-Caparrós, E Fonseca-Aizpuru, M Akasbi, J L Callejas, B de Miguel-Campo, M Pérez de-Lis, M Ramos-Casals, SarcoGEAS-SEMI Registry
Arthritis & Rheumatology (Hoboken; N.J.)
Carlos de la Calle-Fabregat, Ellis Niemantsverdriet, Juan D Cañete, Tianlu Li, Annette H M van der Helm-van Mil, Javier Rodríguez-Ubreva, Esteban Ballestar
Clinical Immunology
Chloé Bost, Françoise Fortenfant, Blancher Antoine, Grégory Pugnet, Yves Renaudineau

Full-Text Articles

Arthritis Research & Therapy
Benjamin Hur, Vinod K Gupta, Harvey Huang, Kerry A Wright, Kenneth J Warrington, Veena Taneja, John M Davis, Jaeyun Sung
Scientific Reports
Jung Woo Lee, Bong Cheol Kwon, Hyo Geun Choi
Arthritis Research & Therapy
Iván Ferraz-Amaro, Alfonso Corrales, Juan Carlos Quevedo-Abeledo, Nuria Vegas-Revenga, Ricardo Blanco, Virginia Portilla, Belén Atienza-Mateo, Miguel Á González-Gay
Scientific Reports
Tianli Meng, Di Wu, Yi Luo, Na Wu, Mengzhu Zhao, Min Shen, Weihong Yu